# Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome

Study · id `cardio:ct-nct02049229` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02049229](<https://clinicaltrials.gov/study/NCT02049229>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02049229

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1800 participants.

## Technical summary

Registry record NCT02049229. Randomized; single masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1800 participants (planned count; ClinicalTrials.gov record NCT02049229, source copy `cardio:ctgov-nct02049229-2015-06-02`, retrieved 2026-10-26)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT02049229, source copy `cardio:ctgov-nct02049229-2015-06-02`, retrieved 2026-10-26)
- Primary completion: 2015-10 (anticipated) (ClinicalTrials.gov record NCT02049229, source copy `cardio:ctgov-nct02049229-2015-06-02`, retrieved 2026-10-26)
- Completion: 2019-10 (anticipated) (ClinicalTrials.gov record NCT02049229, source copy `cardio:ctgov-nct02049229-2015-06-02`, retrieved 2026-10-26)
- Countries: Finland (ClinicalTrials.gov record NCT02049229, source copy `cardio:ctgov-nct02049229-2015-06-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02049229-2015-06-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Titanium-Nitride-Oxide Coated Bio-Active-Stent (Optimax™) to the Drug (Everolimus) -Eluting Stent (Synergy™) in Acute Coronary Syndrome
- Acronym: TIDES-ACS
- Condition: Myocardial Infarction
- Condition: Percutaneous Coronary Intervention
- Condition: Atherosclerosis
- Intervention (Device): percutaneous coronary intervention
- Intervention (Device): percutaneous coronary intervention
- Lead sponsor: The Hospital District of Satakunta
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Titanium-Nitride-Oxide-Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome: The Randomized TIDES-ACS Trial (`cardio:pubmed-32703593`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Titanium-Nitride-Oxide-Coated vs Everolimus-Eluting Stents in Acute Coronary Syndrome: 5-Year Clinical Outcomes of the TIDES-ACS Randomized Clinical Trial (`cardio:pubmed-37203243`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: a7895e829c169c4b6bbb1c2a12424c551769c057804006bb0cefdef6a6bc0698
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
